Featured Stories
SMS will commercialise WAYA StopReflux
New partnership with SMS Pharma Mexico
We are pleased to announce our new partnership with SMS Pharma Mexico. Under this agreement, SMS will commercialise Medis' WAYA StopReflux.
Read MoreNew partnership with Menarini
Launching DIVAmenstral in Greece and Cyprus
We are announcing our new partnership with Menarini, a leading international pharmaceutical and diagnostics company, present in 140 countries worldwide.
Read MoreNEW PARTNERSHIP
Medis and ESTEVE Signed a Distribution Agreement for 10 CEE Countries
The leading Spanish pharmaceutical company ESTEVE has selected Medis as its partner for Central and Eastern Europe (CEE).
Read MoreInterview with Maja Rojšek, Director of the HR Department at Medis
Colleagues are the Ones Who Spread the Good Word about the Company
In a recent interview, Maja Rojšek, Director of the HR Department at Medis, expressed pride in receiving the HR Team of the Year award in the large company...
Read MoreChange in Medis leadership
Medis, the leading commercialization company for the CEE region, has appointed a new CEO
Medis, the leading commercialization company focused on improving access to innovative therapies in the countries of Central and Eastern Europe, has appointed...
Read More#CEOview with Adecco
Why should new talents join Medis?
Martina Perharič, the CEO of Medis, offers her insights on business perception, the role of a leader, and the challenges within the pharmaceutical industry.
Read More